Corcept Therapeutics Inc (FRA:HTD) Stock News, Headlines & Updates
Corcept Therapeutics Inc Stock News from GuruFocus
- 1
Jul 22, 2025
Insider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT)
GuruFocus News • 9:00pm
Jul 14, 2025
Insider Sell: Swisher Daniel N JR Sells 2,200 Shares of Corcept Therapeutics Inc (CORT)
GuruFocus News • 5:00pm
Corcept Therapeutics Submits NDA for Relacorilant to Treat Platinum-Resistant Ovarian Cancer | CORT stock news
GuruFocus News • 8:03am
Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer
Business Wire • 8:00am
Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer | CORT Stock News
GuruFocus News • 7:20am
Jul 09, 2025
Corcept Therapeutics (CORT) Presents Data on Relacorilant for Ovarian Cancer | CORT Stock News
GuruFocus News • 4:30pm
Jun 23, 2025
Corcept Therapeutics Inc (CORT) Announces Positive Results from CATALYST Trial | CORT stock news
GuruFocus News • 4:01pm
Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association's 85th Scientific Sessions with Simultaneous Publication in Diabetes Care
Business Wire • 4:00pm
Corcept Therapeutics (CORT) Shows Promising Results in CATALYST Trial | CORT Stock News
GuruFocus News • 3:47pm
Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association's 85th Scientific Sessions with Simultaneous Publication in Diabetes Care | CORT Stock News
GuruFocus News • 3:46pm
Jun 13, 2025
Insider Sell: Swisher Daniel N JR Sells 2,200 Shares of Corcept Therapeutics Inc (CORT)
GuruFocus News • 9:00pm
Jun 05, 2025
Corcept Therapeutics Inc (CORT) Presents Promising Results from DAZALS Study on ALS Treatment | CORT stock news
GuruFocus News • 6:02am
Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting
Business Wire • 6:00am
Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting | CORT Stock News
GuruFocus News • 5:16am
Corcept Therapeutics (CORT) Reports Promising Survival Data in ALS Study | CORT Stock News
GuruFocus News • 5:16am
Jun 02, 2025
Corcept Therapeutics (CORT) Shows Positive Phase 3 Trial Results for Ovarian Cancer Treatment | CORT Stock News
GuruFocus News • 10:46am
Corcept Presents Pivotal Clinical Data in ASCO Late-Breaker with Simultaneous Publication in The Lancet: Relacorilant Improves Progression-Free and Overall Survival in Patients with Platinum-Resistant
GuruFocus News • 10:30am
May 09, 2025
Insider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT)
GuruFocus News • 9:00pm
May 06, 2025
Corcept Therapeutics (CORT) Faces Price Target Cut Amid Revenue Concerns | CORT Stock News
GuruFocus News • 9:30am
Corcept Therapeutics (CORT) Receives Revised Price Target from Analyst | CORT Stock News
GuruFocus News • 6:02am
Corcept Therapeutics (CORT) Maintains Buy Rating Amid Revised Price Target | CORT Stock News
GuruFocus News • 5:30am
Corcept Therapeutics Inc (CORT) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges
GuruFocus News • 1:08am
Decoding Corcept Therapeutics Inc (CORT): A Strategic SWOT Insight
GuruFocus News • 11:09pm
Q1 2025 Corcept Therapeutics Inc Earnings Call Transcript
GuruFocus News • 11:01pm
Corcept Therapeutics (CORT) Anticipates Future Growth Amid Revenue Increase
GuruFocus News • 7:57pm
May 05, 2025
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Business Wire • 4:00pm
Corcept Therapeutics (CORT) Reports Q1 Revenue Miss | CORT Stock News
GuruFocus News • 3:46pm
Corcept Therapeutics Inc Q1 2025 Earnings: EPS of $0.17 Beats Estimates, Revenue of $157.2M Misses Expectations
GuruFocus News • 3:42pm
CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE | CORT Stock News
GuruFocus News • 3:23pm
Corcept Therapeutics (CORT) Pre-Earnings Options Activity Suggests Modest Movement | CORT Stock News
GuruFocus News • 2:45pm
Corcept Therapeutics (CORT) Set to Announce Q1 Earnings
GuruFocus News • 6:56am
Apr 30, 2025
BlackRock, Inc. Reduces Stake in Corcept Therapeutics Inc
GuruFocus News • 1:34pm
Apr 28, 2025
Corcept Therapeutics Inc (CORT) to Announce Q1 Financial Results and Corporate Update | CORT stock news
GuruFocus News • 4:18pm
- 1
Show
Entries
Headlines
Total 0- 1
No recent news